Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Chemotherapy for gynecologic malignancies

J B Vermorken¹, K Hoekman

¹Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.

Current Opinion in Oncology

|September 1, 1995

Summary

Platinum-based chemotherapy is vital for ovarian cancer. Advances include paclitaxel and intraperitoneal cisplatin, but DNA repair and apoptosis impact resistance, necessitating more targeted gynecologic cancer therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Re-examining post-operative chemoradiotherapy in head and neck cancer: an updated long-term combined analysis of RTOG 9501/EORTC 22931.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Same author

Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature.

Breast cancer research and treatment·2022

Same author

Annals of Oncology: a statement of editorial intent.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Same author

Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Same author

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Same author

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Area of Science:

Gynecologic Oncology
Medical Oncology
Cancer Chemotherapy

Background:

Platinum-based chemotherapy remains a primary treatment for ovarian cancer.
Paclitaxel integration and intraperitoneal cisplatin administration are key advancements.
Chemotherapy resistance is linked to DNA repair and apoptosis processes.

Purpose of the Study:

To review current chemotherapeutic strategies for gynecologic malignancies.
To highlight emerging challenges and future directions in treatment.

Main Methods:

Literature review of recent advances in gynecologic cancer chemotherapy.
Analysis of treatment efficacy and resistance mechanisms.

Main Results:

Related Experiment Videos

Paclitaxel and intraperitoneal cisplatin show promise in ovarian cancer treatment.

Tamoxifen use increases endometrial cancer risk; hormonal therapy is crucial for advanced disease.

Combination chemotherapy offers higher response rates but survival benefits are debated.

Isotretinoin plus interferon alfa-2a is under investigation for cervical cancer.

Conclusions:

There is a critical need for more efficacious and specific agents for gynecologic cancers.
Understanding resistance mechanisms is key to improving treatment outcomes.
Personalized approaches tailored to tumor biology are essential for advancing gynecologic oncology.